CJ CheilJedang Corp (097955)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 104,200.00 |
|---|---|
| 52-week range | 103,000.00 – 144,200.00 |
| Return, 1 month / 3 months | −5.4% / −14.2% |
| Return, 1 year / 3 years | −20.6% / −3.9% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 19.7% |
| Worst drawdown (1 year) | -24.6% |
| Average daily value traded | 718.21M KRW |
| Dividend yield | 5.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CJ CheilJedang Corp is a Korean food and bio company based in Seoul. It makes and sells packaged and processed foods, including dumplings, instant noodles, seasonings, sauces and frozen meals, for households and foodservice customers in Korea and overseas. The company also produces fermentation-based ingredients such as amino acids and feed additives for animal nutrition and industrial users, and it runs a food ingredients and materials business serving manufacturers.
The shares are listed on the Korea Stock Exchange in Korea under the code 097955, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CJ CheilJedang Corp (097955) trades on the Korea Stock Exchange in Korea. It last closed at KRW 104,200.00 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 249 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.6% and over the last three months it fell 14.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -16.7% | ||
| From 52-week high | -27.2% | ||
| Momentum | 36 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -14.2% | ||
| 6-month return | -22.9% | ||
| 12-month return, skipping the last month | -16.0% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.6% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 718.21M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 87 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 5.8% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.6% |
|---|---|
| 1 month | −5.4% |
| 3 months | −14.2% |
| 6 months | −22.9% |
| 1 year | −20.6% |
| 3 years | −3.9% |
| 5 years | −34.5% |
Signals
| 50-day / 200-day average | 116,032.76 / 125,117.55 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2,345.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Aug 2026 | KRW 1,500.0000 |
| 28 May 2026 | KRW 1,500.0000 |
| 26 Feb 2026 | KRW 1,550.0000 |
| 27 Nov 2025 | KRW 1,500.0000 |
| 28 Aug 2025 | KRW 1,500.0000 |
| 29 May 2025 | KRW 1,500.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.